# Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition

> **NCT01503437** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 22 (actual)

## Conditions studied

- Fasting

## Interventions

- **DRUG:** Olanzapine OD Tablets 5 mg

## Key facts

- **NCT ID:** NCT01503437
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2006-11
- **Final completion:** 2006-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01503437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01503437, "Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01503437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*